NCT07330401

Brief Summary

Goal: The goal of this observational study is to evaluate the genotoxic and cytotoxic effects of OPG and CBCT on exfoliated buccal mucosal cells Main question: Does CBCT cause greater genotoxic and cytotoxic effects on buccal mucosal cells compared with OPG? Buccal epithelial cells were gently exfoliated from participants scheduled to undergo OPG or CBCT imaging. Samples were collected twice-immediately before exposure and again 10-12 days afterward. All participants provided written informed consent prior to inclusion in the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

November 22, 2025

Last Update Submit

January 2, 2026

Conditions

Keywords

Buccal Mucosa CellsMicronucleus AssayDental RadiographyOrthopantomogram (OPG)Cone Beam Computed Tomography (CBCT)Low-Dose Ionizing RadiationAge-Related Radiosensitivity

Outcome Measures

Primary Outcomes (1)

  • Primary outcome: Change in micronucleated buccal epithelial cells measured by the Buccal Micronucleus Cytome Assay (MN per 2,000 cells)

    Micronucleated buccal epithelial cells will be quantified using the Buccal Micronucleus Cytome Assay following Sarto et al. (1987) criteria. For each participant, 2,000 exfoliated buccal cells will be evaluated at two time points: 1. immediately before dental X-ray exposure, and 2. approximately 10 ± 2 days after exposure. The primary analysis will report the change in the number of micronucleated cells per 2,000 cells (post-pre difference). Micronuclei are identified based on size, morphology, staining characteristics, and separation from the main nucleus. Higher post-pre values indicate greater genotoxic response.

    10 ±12 days after exposure

Study Arms (4)

OPG,15-25 years old

CBCT,15-25 years old

OPG,40-50 years old

CBCT,40-50 years old

Eligibility Criteria

Age15 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 15-25 years and 40-50 years undergoing routine dental radiographic examination (OPG or CBCT), with follow-up buccal cell sampling for cytogenetic analysis.

You may qualify if:

  • Underwent routine dental imaging using OPG or CBCT (no additional radiation for research purposes).
  • Age 15-25 years or 40-50 years at the time of enrolment.
  • Able and willing to provide written informed consent (or consent from a legal guardian for minors).
  • Agreed to provide pre-exposure and follow-up buccal epithelial cell samples.

You may not qualify if:

  • History of systemic diseases, including but not limited to leukemia, lymphoma, rheumatic disorders, or diabetes mellitus.
  • Prior exposure to head-and-neck radiotherapy, immunosuppressive drugs, or cytotoxic medications.
  • Presence of active infectious diseases or acute/chronic inflammatory conditions at the time of enrolment.
  • Clinically visible oral pathological lesions, including mucosal abnormalities, gingivitis, or periodontitis.
  • Use of removable intra-oral prostheses or appliances (e.g., dentures, orthodontic appliances).
  • Engagement in smoking, alcohol consumption, or betel-nut chewing.
  • Diagnostic or therapeutic X-ray exposure within the preceding 3 months.
  • Previous or current oral mucosal diseases, including oral lichen planus, recurrent aphthous stomatitis, oral candidiasis, HSV infection, leukoplakia, oropharyngeal carcinoma, mucous membrane pemphigoid, or pemphigus vulgaris.
  • Presence of persistent local irritants, including ill-fitting dental prostheses, sharp teeth/restorations, chemical irritation (acidic foods, alcohol-based mouthwash), or recurrent thermal injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

universiti Sains Malaysia hospital

Kota Bharu, Kelantan, 25000, Malaysia

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
master

Study Record Dates

First Submitted

November 22, 2025

First Posted

January 9, 2026

Study Start

October 1, 2024

Primary Completion

July 1, 2025

Study Completion

September 30, 2025

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations